FAQ/Help |
Calendar |
Search |
Today's Posts |
|
ALS News & Research For postings of news or research links and articles related to ALS |
Reply |
|
Thread Tools | Display Modes |
12-13-2018, 02:57 PM | #1 | |||
|
||||
Grand Magnate
|
A $63 billion biotech is returning to the scene of its worst failure in search of new treatments for a deadly muscle disorder
Biogen is adding ALS drugs to its research pipeline in search of blockbusters - Business Insider . . . I did not realize Biogen was worth $63 million . . . |
|||
Reply With Quote |
Reply |
|
|
Similar Threads | ||||
Thread | Forum | |||
Just that one scene | Social Chat |